Cargando…
Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database
With the incidence of central and peripheral nervous system disorders on the rise, neurosurgical procedures paired with the careful administration of select medications have become necessary to optimize patient outcomes. Despite efforts to decrease the over-prescription of common addictive drugs, su...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452193/ https://www.ncbi.nlm.nih.gov/pubmed/37626682 http://dx.doi.org/10.3390/biomedicines11082185 |
_version_ | 1785095607799513088 |
---|---|
author | Doad, Jagroop Gupta, Nithin Leavitt, Lydia Hart, Alexandra Nguyen, Andrew Kaura, Shawn DeStefano, Frank McCray, Edwin Lucke-Wold, Brandon |
author_facet | Doad, Jagroop Gupta, Nithin Leavitt, Lydia Hart, Alexandra Nguyen, Andrew Kaura, Shawn DeStefano, Frank McCray, Edwin Lucke-Wold, Brandon |
author_sort | Doad, Jagroop |
collection | PubMed |
description | With the incidence of central and peripheral nervous system disorders on the rise, neurosurgical procedures paired with the careful administration of select medications have become necessary to optimize patient outcomes. Despite efforts to decrease the over-prescription of common addictive drugs, such as opioids, prescription costs continue to rise. This study analyzed temporal trends in medication use and cost for spinal fusion and brain tumor resection procedures. The Medicare Part B Database was queried from 2016 to 2020 for data regarding spinal fusion and brain tumor resection procedures, while the Part D Database was used to extract data for two commonly prescribed medications for each procedure. Pearson’s correlation coefficient and linear regression were completed for the analyzed variables. The results showed a significant negative correlation between the number of spinal procedure beneficiaries and the cost of methocarbamol, as well as between the annual percent change in spinal beneficiaries and the annual percent change in oxycodone cost. Linear regression revealed that oxycodone cost was the only parameter with a statistically significant model. Moving forward, it is imperative to combat rising drug costs, regardless of trends seen in their usage. Further studies should focus on the utilization of primary data in a multi-center study. |
format | Online Article Text |
id | pubmed-10452193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104521932023-08-26 Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database Doad, Jagroop Gupta, Nithin Leavitt, Lydia Hart, Alexandra Nguyen, Andrew Kaura, Shawn DeStefano, Frank McCray, Edwin Lucke-Wold, Brandon Biomedicines Article With the incidence of central and peripheral nervous system disorders on the rise, neurosurgical procedures paired with the careful administration of select medications have become necessary to optimize patient outcomes. Despite efforts to decrease the over-prescription of common addictive drugs, such as opioids, prescription costs continue to rise. This study analyzed temporal trends in medication use and cost for spinal fusion and brain tumor resection procedures. The Medicare Part B Database was queried from 2016 to 2020 for data regarding spinal fusion and brain tumor resection procedures, while the Part D Database was used to extract data for two commonly prescribed medications for each procedure. Pearson’s correlation coefficient and linear regression were completed for the analyzed variables. The results showed a significant negative correlation between the number of spinal procedure beneficiaries and the cost of methocarbamol, as well as between the annual percent change in spinal beneficiaries and the annual percent change in oxycodone cost. Linear regression revealed that oxycodone cost was the only parameter with a statistically significant model. Moving forward, it is imperative to combat rising drug costs, regardless of trends seen in their usage. Further studies should focus on the utilization of primary data in a multi-center study. MDPI 2023-08-03 /pmc/articles/PMC10452193/ /pubmed/37626682 http://dx.doi.org/10.3390/biomedicines11082185 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Doad, Jagroop Gupta, Nithin Leavitt, Lydia Hart, Alexandra Nguyen, Andrew Kaura, Shawn DeStefano, Frank McCray, Edwin Lucke-Wold, Brandon Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database |
title | Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database |
title_full | Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database |
title_fullStr | Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database |
title_full_unstemmed | Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database |
title_short | Economic Trends in Commonly Used Drugs for Spinal Fusion and Brain Tumor Resection: An Analysis of the Medicare Part D Database |
title_sort | economic trends in commonly used drugs for spinal fusion and brain tumor resection: an analysis of the medicare part d database |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452193/ https://www.ncbi.nlm.nih.gov/pubmed/37626682 http://dx.doi.org/10.3390/biomedicines11082185 |
work_keys_str_mv | AT doadjagroop economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase AT guptanithin economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase AT leavittlydia economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase AT hartalexandra economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase AT nguyenandrew economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase AT kaurashawn economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase AT destefanofrank economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase AT mccrayedwin economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase AT luckewoldbrandon economictrendsincommonlyuseddrugsforspinalfusionandbraintumorresectionananalysisofthemedicarepartddatabase |